Details of the Drug

General Information of Drug (ID: DMMTL7V)

Drug Name
Hemoglobin raffimer
Synonyms Hemolink; Cross-linked hemoglobin, Hemosol
Indication
Disease Entry ICD 11 Status REF
Anemia 3A00-3A9Z Phase 2/3 [1]
ATC Code
B05AA09: Hemoglobin raffimer
B05AA: Blood substitutes and plasma protein fractions
B05A: BLOOD AND RELATED PRODUCTS
B05: BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS
B: BLOOD AND BLOOD FORMING ORGANS
Cross-matching ID
UNII
69HRT16MGP
DrugBank ID
DB13658
TTD ID
D0H4CB

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Hemoglobin (HB) TTQO71U HBA_HUMAN Modulator [2]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 ClinicalTrials.gov (NCT00038454) Phase II Study To Evaluate The Safety and Efficacy of Hemoglobin Raffimer in Patients Undergoing First Time CABG Surgery. U.S. National Institutes of Health.
2 Use of hemoglobin raffimer for postoperative life-threatening anemia in a Jehovah's Witness. Can J Anaesth. 2005 Apr;52(4):369-73.